ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 530,72
-1,03%
Dow Jones
39 164,06
0,09%
DAX
18 210,55
0,26%
Brent Oil
85,495
0,09%
Bitcoin
61 903,65
0,48%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Yumanity Therapeutics Inc (YMTX)

  7. Yumanity Therapeutics Inc (YMTX) Actualités

YMTX

Yumanity Therapeutics (YMTX)

Yumanity Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:YMTX
DateHeureSourceTitreSymboleSociété
16/12/202220h58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:YMTXYumanity Therapeutics Inc
16/12/202216h38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:YMTXYumanity Therapeutics Inc
15/12/202212h43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202213h30GlobeNewswire Inc.Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214h45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214h16GlobeNewswire Inc.Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202212h09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202222h27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202222h15GlobeNewswire Inc.Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.NASDAQ:YMTXYumanity Therapeutics Inc
04/11/202221h53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:YMTXYumanity Therapeutics Inc
29/08/202212h30GlobeNewswire Inc.Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
04/08/202222h15GlobeNewswire Inc.Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
06/06/202212h30GlobeNewswire Inc.Yumanity Therapeutics Announces Definitive Agreements for Two Strategic TransactionsNASDAQ:YMTXYumanity Therapeutics Inc
12/05/202222h45GlobeNewswire Inc.Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
25/04/202222h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:YMTXYumanity Therapeutics Inc
25/04/202222h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202221h36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202221h15GlobeNewswire Inc.Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
17/02/202214h30GlobeNewswire Inc.Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces RestructuringNASDAQ:YMTXYumanity Therapeutics Inc
14/02/202223h40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:YMTXYumanity Therapeutics Inc
05/02/202200h48GlobeNewswire Inc.Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:YMTXYumanity Therapeutics Inc
19/01/202213h30GlobeNewswire Inc.Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739  NASDAQ:YMTXYumanity Therapeutics Inc
11/01/202214h00GlobeNewswire Inc.Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External CollaborationsNASDAQ:YMTXYumanity Therapeutics Inc
04/01/202214h00GlobeNewswire Inc.Yumanity Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceNASDAQ:YMTXYumanity Therapeutics Inc
20/12/202122h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:YMTXYumanity Therapeutics Inc
03/12/202122h17Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:YMTXYumanity Therapeutics Inc
19/11/202122h56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:YMTXYumanity Therapeutics Inc
16/11/202122h30GlobeNewswire Inc.Yumanity Therapeutics to Present at Multiple Upcoming November Investor ConferencesNASDAQ:YMTXYumanity Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMTX

Dernières Valeurs Consultées

AMEX
FESM
Fidelity Enhanced Small ...
BIT
UC7KAY
Unicredit Bank
LSE
LZ58
Citi Fun 25
NYSE
HKG
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés